Gm Advisory Group, Inc. Dexcom Inc Transaction History

Gm Advisory Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $2,426 - $3,089	22 Added 0.17%	13,084 $1.48 Million
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $19,874 - $24,377	-174 Reduced 1.31%	13,062 $1.81 Million
Q4 2023 Feb 12, 2024	BUY	$75.49 - $124.16 $70,658 - $116,213	936 Added 7.61%	13,236 $1.64 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $50,689 - $81,240	589 Added 5.03%	12,300 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $208,181 - $242,443	-1,851 Reduced 13.65%	11,711 $1.5 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $379,600 - $448,658	-3,650 Reduced 21.21%	13,562 $1.58 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $1,019 - $1,472	12 Added 0.07%	17,212 $1.95 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.4 Million - $1.72 Million	-18,280 Reduced 51.52%	17,200 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $2.05 Million - $4 Million	30,130 Added 563.18%	35,480 $2.64 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $503,328 - $696,569	5,350 New	5,350 $2.74 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Gm Advisory Group, Inc. with notifications on news.